this underperformed pharma stock is trading well below its all time high. Could not rally last time after good quarterly result. it appears its break out is taking place slow and steadily. It is a f&o stock hence not a study on f&o perceptive. Target has been achieved Target 4 may be achieved in due course. don't forget to like my post. follow me to get updates
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.